Fineline Cube

Follow:
14436 Articles
Sihuan Pharma's Xuanyuening Granted New Indication Review in China
CompanyDrug

Sihuan Pharma’s Xuanyuening Granted New Indication Review in China

Johnson & Johnson Launches Tremfya IV in China for Inflammatory Bowel Diseases
CompanyDrug

Johnson & Johnson Launches Tremfya IV in China for Inflammatory Bowel Diseases

"Deep Surgery Secures Pre-Series A Funding for Microsurgery Robot Expansion
CompanyDeals

Deep Surgery Secures Pre-Series A Funding for Microsurgery Robot Expansion

ImmuneOnco Appoints Zhuli Wu as Chief Medical Officer to Lead Clinical Strategy
Company

ImmuneOnco Appoints Zhuli Wu as Chief Medical Officer to Lead Clinical Strategy

Hengrui Pharmaceuticals Launches Aiweida for HER2-Mutated NSCLC in China
CompanyDrug

Hengrui Pharmaceuticals Launches Aiweida for HER2-Mutated NSCLC in China

Suzhou Sinus Medtech Wins FDA Breakthrough Designation for oHCM Ablation System
CompanyMedical Device

Suzhou Sinus Medtech Wins FDA Breakthrough Designation for oHCM Ablation System

Novartis' PSMAddition Trial Yields Positive Results for Pluvicto in mHSPC
CompanyDrug

Novartis’ PSMAddition Trial Yields Positive Results for Pluvicto in mHSPC

Innovent Biologics' Xinbiyue Approved for Macau Market
CompanyDrug

Innovent Biologics’ Xinbiyue Approved for Macau Market

Innogen Pharma Resubmits Hong Kong IPO Application With Promising Diabetes Drug
CompanyDeals

Innogen Pharma Resubmits Hong Kong IPO Application With Promising Diabetes Drug

Harrow Signs Licensing Deal for Formosa's Byqlovi in US Market
CompanyDeals

Harrow Signs Licensing Deal for Formosa’s Byqlovi in US Market

FDA Approves Merck's Enflonsia for Infant RSV Protection
CompanyDrug

FDA Approves Merck’s Enflonsia for Infant RSV Protection

Sino Biopharmaceutical Gains CDE Approval for TQC3721 COPD Trial
CompanyDrug

Sino Biopharmaceutical Gains CDE Approval for TQC3721 COPD Trial